NCT07250178 2026-01-07
ONSD as an ICP Marker in vNOTES and TLH
Saglik Bilimleri Universitesi Gazi Yasargil Training and Research Hospital
Phase NA Completed
Clinical Trials
47 trialsNCT06067971 2025-09-12
ENDORA2
University Hospital, Clermont-Ferrand
Phase NA Completed
NCT06959966 2025-05-07
Effects of Oligo-fucoidan on Leiomyoma Patients
Taipei Medical University
Phase EARLY_PHASE1 Completed
NCT06115408 2024-12-16
Evaluation of Using Dienogest and N-Acetyl Cysteine on the Volume of Uterine Leiomyoma
Ain Shams University
Phase 2/3 Completed
NCT02563392 2024-08-13
ORAM
University Hospital, Geneva
Phase NA Completed
NCT06524934 2024-07-29
Virtual Reality's Role in See&Treat Hysteroscopy
Federico II University
Phase NA Completed
NCT03751124 2024-06-25
Study of Relugolix With Estradiol and Norethindrone Acetate in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
Myovant Sciences GmbH
Phase 3 Completed
NCT05086770 2023-07-14
Comparison of Pain After Uterine Artery Embolization Using Gelatin Microsphere or Tris-acryl Gelatin Microsphere
Next Biomedical Co., Ltd.
Phase NA Completed
NCT04874246 2023-06-26
VALENTINE
Seoul National University Hospital
Phase NA Completed
NCT05761418 2023-03-09
Preoperative Vaginal Dinoprostone Versus Misoprostone in Abdominal Myomectomy
Beni-Suef University
Phase 3 Completed
NCT04482959 2022-04-06
Intraoperative Carbetocin to Decrease Blood Loss During Hysteroscopic Myomectomy
Mansoura University Hospital
Phase 4 Completed
NCT05108597 2021-11-05
Effect of Rectal Misoprostol in Reducing Intra-operative Blood Loss During Myomectomy
Pak Emirates Military Hospital
Phase 3 Completed
NCT04672421 2021-09-29
The Efficacy and Safety of Medicurtain® in Patients With Total Laparoscopic Hysterectomy (Pivotal Study)
Shin Poong Pharmaceutical Co. Ltd.
Phase NA Completed
NCT02520414 2021-03-26
Symphion® System In-Office Study
Minerva Surgical, Inc.
Phase NA Completed
NCT01338831 2020-12-17
Phase I Study of LFA102 in Patients With Prolactin Receptor-positive Castration-resistant Prostate Cancer or Prolactin Receptor-positive Metastatic Breast Cancer
Novartis
Phase 1 Completed
NCT03535610 2020-09-04
EMBOSOFT I
Scitech Produtos Medicos SA
Phase NA Completed
NCT03701529 2020-09-04
Effect of Anesthetic Agents on Optic Nerve Sheath Diameter
Hallym University Kangnam Sacred Heart Hospital
Phase NA Completed
NCT02829333 2020-01-22
The Effect of Anesthetic Technique on VEGF-C and PGE2
General Hospital of Ningxia Medical University
Phase NA Completed
NCT03328260 2020-01-03
High Intensity Focused Ultrasound in Uterine Myoma
Seoul National University Hospital
Phase NA Completed
NCT00044876 2019-12-17
Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03009812 2019-04-08
Transverse vs Longitudinal Incision in Myomectomy
Ain Shams University
Phase NA Completed
NCT03847077 2019-02-20
PETAL
Loyola University
Phase NA Completed
NCT02392585 2019-02-12
Single or Triple Uterine Tourniquet at Myomectomy
Ataturk University
Phase NA Completed
NCT00365989 2019-02-05
MR Guided Focused Ultrasound Treatment of Uterine Fibroids With Enhanced Sonication
InSightec
Phase 3 Completed
NCT00295217 2018-12-20
MR Guided Focused Ultrasound Surgery in the Treatment of Uterine Fibroids: Software V4.2 Validation
InSightec
Phase 3 Completed
NCT02059954 2018-04-17
Vaginal vs. Laparoscopic Hysterectomy
Medical University of Graz
Phase NA Completed
NCT00995878 2018-01-12
The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids.
Mayo Clinic
Phase 4 Completed
NCT01715597 2017-10-31
Study on the Effect of Intravenous Ascorbic Acid on Intraoperative Blood Loss in Women With Uterine Myoma
Seoul National University Hospital
Phase 3 Completed
NCT00332033 2017-07-02
Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids)
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT02293447 2016-05-12
Intra-arterial Lidocaine for Pain Control Post Uterine Fibroid Embolization
University Health Network, Toronto
Phase 4 Completed
NCT01588899 2015-10-22
China Clinical Trial for Therapeutic MR-HIFU Ablation of Uterine Fibroids
Philips Healthcare
Phase NA Completed
NCT01873378 2015-08-11
GnRH Agonist Pretreatment in Hysteroscopic Myomectomy
Azienda Ospedaliera S. Maria della Misericordia
Phase NA Completed
NCT01984632 2015-07-31
Barbed Suture in Single-port Laparoscopic Myomectomy
CHA University
Phase 3 Completed
NCT02086435 2015-04-21
IEME
University Magna Graecia
Phase NA Completed
NCT02056717 2015-04-17
Use of Dexamethasone in Uterine Artery Embolization
Severance Hospital
Phase NA Completed
NCT02049242 2014-12-23
Uterine Tourniquet at Open Myomectomy
Ataturk University
Phase NA Completed
NCT01937104 2014-10-30
ONSD
Chosun University Hospital
Phase NA Completed
NCT01069094 2014-06-30
A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
Repros Therapeutics Inc.
Phase 1/2 Completed
NCT01492179 2014-05-28
PoPuLAR
Örebro University, Sweden
Phase 4 Completed
NCT00837161 2012-12-04
Pilot Study of MRI-Guided High Intensity Focused Ultrasound Ablation of Uterine Fibroids
Philips Healthcare
Phase 1/2 Completed
NCT00897897 2012-12-04
Therapeutic Magnetic Resonance Imaging (MRI)-Guided High Intensity Focused Ultrasound (HIFU) Ablation of Uterine Fibroids
Philips Healthcare
Phase NA Completed
NCT01064960 2012-12-04
Therapeutic MRI-HIFU Ablation of Uterine Fibroids in a 3T MRI Scanner
Philips Healthcare
Phase 3 Completed
NCT01141062 2012-12-04
HIFU
Philips Healthcare
Phase 3 Completed
NCT01379313 2012-10-01
The Effect of Different I:E Ratio on Gas Exchange of Patients Undergoing Gynecologic Laparoscopic Surgery With Trendelenburg Position
Samsung Medical Center
Phase NA Completed
NCT01064128 2011-07-20
Study of Different Pain Scores in Single-Port Access (SPA) Laparoscopic Hysterectomy Versus Conventional Laparoscopic Hysterectomy
Samsung Medical Center
Phase 3 Completed
NCT00444704 2009-07-10
Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PRA-027 Administered to Healthy Japanese Females
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 1 Completed
NCT00427544 2007-12-05
Study of the Safety, Tolerability, and PK of PRA-027 Administered to Women of Nonchildbearing Potential
Wyeth is now a wholly owned subsidiary of Pfizer
Phase 1 Completed